Craft

Harvard Bioscience

Stock Price

$2.5

2024-10-29

Market Capitalization

$106.8 M

2024-10-29

Revenue

$86.6 M

FY, 2025

Harvard Bioscience Summary

Company Summary

Overview
Harvard Bioscience is a global developer, manufacturer, and marketer of a broad range of specialized products, primarily apparatus and scientific instruments used to advance life science research at pharmaceutical and biotechnology companies, universities and government laboratories worldwide. The Company sells its products to thousands of researchers through its full-line catalog (and various other specialty catalogs), its websites, and through distributors, including GE Healthcare, Thermo Fisher Scientific Inc., and VWR.
Type
Public
Status
Active
Founded
1901
HQ
Holliston, MA, US | view all locations
Website
https://www.harvardbioscience.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • John Duke

    John Duke, President and Chief Executive Officer

  • Mark Frost

    Mark Frost, Interim Chief Financial Officer and Treasurer

  • Ryan Wallace

    Ryan Wallace, Senior Vice President, Global Sales

  • Diane Houston

    Diane Houston, Vice President, Global IT

LocationsView all

1 location detected

  • Holliston, MA HQ

    United States

    84 October Hill Road, Suite 10

Harvard Bioscience Financials

Summary Financials

Revenue (Q1, 2026)
$20.8M
Gross profit (Q1, 2026)
$12.2M
Net income (Q1, 2026)
($3.4M)
Cash (Q1, 2026)
$7.1M
EBIT (Q1, 2026)
($1.2M)
Enterprise value
$142.3M

Footer menu